| |
Present study population
|
Graz
|
Innsbruck
|
Vienna
|
Mannheim
|
|---|
|
Number of BALs/patients
|
149/133
|
70/61
|
51/49
|
18/13
|
10/10
|
|
Sex
| | | | | |
|
Male
|
87 (65.4%)
|
45 (51.7%)
|
28 (32.2%)
|
6 (6.9%)
|
8 (9.2%)
|
|
Female
|
46 (34.6%)
|
16 (34.8%)
|
21 (45.7%)
|
7 (15.2%)
|
2 (4.3%)
|
|
Median age (range)
|
60 (19 to 85)
|
66 (19 to 83)
|
58 (26 to 85)
|
59.5 (41 to 74)
|
55.5 (40 to 75)
|
|
Type of ICU admission (BALs)
| | | | | |
|
Medical
|
121/149 (81.2%)
|
60/70 (85.7%)
|
35/51 (68.6%)
|
16/18 (88.9%)
|
10/10 (100%)
|
|
Neurologic
|
6/149 (4%)
|
5/70 (2.9%)
|
1/51 (2%)
|
–
|
–
|
|
Elective surgery
|
2/149 (1.3%)
|
–
|
1/51 (2%)
|
1/18 (5.6%)
|
–
|
|
Emergency surgery
|
8/149 (5.4%)
|
4/70 (5.7%)
|
4/51 (7.8%)
|
–
|
–
|
|
Trauma
|
12/149 (8.1%)
|
1/70 (1.4%)
|
10/51 (19.6%)
|
1/18 (5.6%)
|
–
|
|
Primary underlying disease (BALs)
| | | | | |
|
Pulmonary disease
|
44/149 (29.5%)
|
21/70 (30%)
|
14/51 (27.5%)
|
6/18 (33.3%)
|
3/10 (30%)
|
|
Heart disease
|
25/149 (16.8%)
|
17/70 (24.3%)
|
4/51 (7.8%)
|
4/18 (22.2%)
|
–
|
|
Hematologic malignancies
|
19/149 (12.8%)
|
8/70 (11.4%)
|
3/51 (5.9%)
|
2/18 (11.1%)
|
6/10 (60%)
|
|
Trauma
|
12/149 (8.1)
|
1/70 (1.4%)
|
10/51 (19.6%)
|
1/18 (5.6%)
|
–
|
|
Neurologic disease
|
14/149 (9.4%)
|
11/70 (15.7%)
|
3/51 (5.9%)
|
–
|
–
|
|
Gastrointestinal disease
|
13/149 (8.7%)
|
3/70 (4.3%)
|
7/51 (13.7%)
|
3/18 (16.7%)
|
–
|
|
Metabolic disease
|
4/149 (2.7%)
|
1/70 (1.4%)
|
3/51 (5.9%)
|
–
|
–
|
|
Other malignancies
|
5/149 (3.4%)
|
3/70 (4.3%)
|
2/51 (3.9%)
|
–
|
–
|
|
Rheumatologic disease
|
4/149 (2.7%)
|
3/70 (4.3%)
|
–
|
–
|
1/10 (10%)
|
|
Others
|
9/149 (6%)
|
2/70 (2.9%)
|
5/51 (9.8%)
|
2/18 (11.1%)
|
–
|
|
IPA classification
| | | | | |
|
Proven IPA (BALs/patients)
|
4/2
|
–
|
–
|
3/1
|
1/1
|
|
Probable IPA (BALs/patients)
|
16/14
|
6/6
|
8/7
|
2/1
|
–
|
|
Possible IPA (BALs/patients)
|
21/20
|
6/5
|
6/6
|
–
|
9/9
|
|
No IPA (BALs/patients)
|
108/97
|
58/50
|
37/36
|
13/11
|
–
|
-
aBAL, Bronchoalveolar lavage; COPD, Chronic obstructive pulmonary disease; IPA, Invasive pulmonary aspergillosis.
